• Biocomposites responds to NHS supply crisis by bringing forward launch of its SYNICEMTM bone cement products in the UK • Over 500,000 SYNICEMTM bone cement packs are already used by surgeons globally every year to help their patients • The British firm is doubling global production of its SYNICEMTM bone cement products to one million packs a […]
The Novo Nordisk Foundation, Gates Foundation, and Wellcome will support locally led evaluations of AI tools that have the potential to improve health outcomes in low- and middle-income countriesThe first call for proposals, now open, focuses on mature AI tools that support decision-making in primary and community health settings New Delhi, India, 20 February 2026 […]
Lund, Sweden, 18 February 2026. Hansa Biopharma AB, (“Hansa” or “the Company”), (Nasdaq Stockholm: HNSA), today announced that its Biologics License Application (BLA) for imlifidase has been accepted by the U.S. Food and Drug Administration (FDA). FDA’s filing review was completed on day 60 which is meant to verify that the submission is substantially complete […]
New prestigious grants support Lario’s unique portfolio of calcium channel programmes Indication expansion into Parkinson’s disease, and PTSD (post-traumatic stress disorders) Builds on prior support from The Michael J. Fox Foundation and further validates Lario’s precision neuroscience platform Edinburgh, UK – 19 February 2026 – Lario Therapeutics (“Lario” or the “Company”), a biopharmaceutical company developing […]
Round led by Heran Partners and joined by Clave Capital, Inveready and Bio&Tech Smart Capital Financing will enable Pharmacelera to build ongoing relationships with major pharma and biotech customers in the US Pharmacelera’s platform scours vast chemical ‘exaSpace’ accurately for novel molecules Barcelona, Spain, February 18, 2026 – Pharmacelera, a deep tech company applying Quantum […]
